Item 5.07 Submission of Matters to a Vote of Security Holders

Acadia Healthcare Company, Inc. (the "Company") held its annual meeting of stockholders (the "Annual Meeting") on May 19, 2022. The proposals considered at the Annual Meeting were voted on as follows:



1.   The individuals listed below were elected to serve as Class II directors
until the Company's annual meeting of stockholders in 2025 or until their
successors have been elected and take office. The voting results were as
follows:

                                                                      Broker
                        For            Against         Abstain       Non-Votes
Jason R. Bernhard     83,048,381        1,425,379        25,925       1,969,872
William F. Grieco     63,327,920       21,145,829        25,936       1,969,872
Reeve B. Waud         46,059,659       38,243,796       196,230       1,969,872

2. The Company's stockholders approved, on a non-binding advisory basis, the compensation of the Company's Named Executive Officers (as defined in the Company's definitive proxy statement filed with the SEC on April 8, 2022), by the following vote:



   For        Against    Abstain   Broker Non-Votes
83,326,381   1,142,179   31,125       1,969,872

3. The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022, by the following vote:



   For       Against   Abstain
85,844,983   599,745   24,829

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses